A Randomized Double-Blind Study Comparing Oseltamivir Versus Placebo for the Treatment of Influenza in Low Risk Adults
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 22 Nov 2017
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 20 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 02 Feb 2017 Planned primary completion date changed from 1 Jun 2015 to 1 Jun 2019.
- 07 Jul 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Sep 2014 to 1 Jun 2015.